LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Chemical disaggregation of alpha-synuclein fibrils as a therapy for synucleinopathies.

Photo from wikipedia

Protein aggregate formed by alpha-synuclein is the hallmark of a series of neurodegenerative disorders known as synucleinopathies (also known as Lewy body diseases), including Parkinson’s disease (PD), dementia with Lewy… Click to show full abstract

Protein aggregate formed by alpha-synuclein is the hallmark of a series of neurodegenerative disorders known as synucleinopathies (also known as Lewy body diseases), including Parkinson’s disease (PD), dementia with Lewy bodies, and multiple system atrophy (MSA) (1). Globally PD alone affects the lives of more than 10 million people. In synucleinopathies, soluble, monomeric alpha-synuclein aggregates into fibrillar structures. The fibrillar alpha-synucleins, together with other protein aggregates, lipid

Keywords: synuclein; alpha synuclein; synuclein fibrils; disaggregation alpha; chemical disaggregation

Journal Title: Proceedings of the National Academy of Sciences of the United States of America
Year Published: 2023

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.